COVID-19 induced ARDS, and the use of galantamine to activate the cholinergic anti-inflammatory pathway
| Errataetall: |
CommentOn: Best Pract Res Clin Rheumatol. 2014 Aug;28(4):625-35. - PMID 25481554 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:145 |
|---|---|
| Enthalten in: |
Medical hypotheses - 145(2020) vom: 15. Dez., Seite 110331 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Ahmad, Farrukh [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 09.12.2020 Date Revised 12.01.2021 published: Print-Electronic CommentOn: Best Pract Res Clin Rheumatol. 2014 Aug;28(4):625-35. - PMID 25481554 Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.mehy.2020.110331 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM316084883 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM316084883 | ||
| 003 | DE-627 | ||
| 005 | 20231225160321.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.mehy.2020.110331 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1053.xml |
| 035 | |a (DE-627)NLM316084883 | ||
| 035 | |a (NLM)33038588 | ||
| 035 | |a (PII)S0306-9877(20)31920-4 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Ahmad, Farrukh |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a COVID-19 induced ARDS, and the use of galantamine to activate the cholinergic anti-inflammatory pathway |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 09.12.2020 | ||
| 500 | |a Date Revised 12.01.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentOn: Best Pract Res Clin Rheumatol. 2014 Aug;28(4):625-35. - PMID 25481554 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Comment | |
| 650 | 7 | |a Cholinesterase Inhibitors |2 NLM | |
| 650 | 7 | |a Galantamine |2 NLM | |
| 650 | 7 | |a 0D3Q044KCA |2 NLM | |
| 773 | 0 | 8 | |i Enthalten in |t Medical hypotheses |d 1983 |g 145(2020) vom: 15. Dez., Seite 110331 |w (DE-627)NLM00007487X |x 1532-2777 |7 nnns |
| 773 | 1 | 8 | |g volume:145 |g year:2020 |g day:15 |g month:12 |g pages:110331 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.mehy.2020.110331 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 145 |j 2020 |b 15 |c 12 |h 110331 | ||